ADD / ADHD, ADD / ADHD Medication

ADHD Drug Market: $2.7 billion

A brief report on Pharmaceutical Business Review notes the current market is $2.7 billion per year and that this is expected to rise to $3.3 billion by 2015. The article also notes: “Although ADHD drugs have demonstrated significant efficacy in improving the three main symptoms of ADHD – inattention, hyperactivity and impulsivity – none have shown efficacy in treating the cognitive deficits of ADHD.
Given the amount of money involved its not surprising that manufacturers are keen to see as many children on Ritalin as possible.

Coverage on Myomancy.com: Ritalin May Lead To Depression in Later Life, New ADHD Drug Approved in UK

Other sites: Death From Ritalin, NIDA InfoFacts: Methylphenidate (Ritalin), Drug makers find ways to circumvent an advertising ban and promote psychiatric drugs for children, ADHD Info sponsored by Novartis, makers of Ritalin.

One Comment

Comments are closed.